What is the HQL stock price prediction for next 2 weeks?

According to our price prediction algorithm,Tekla Life Sciences Investors (HQL) price will be around $17.86 in the next 2 weeks. This means it will increase by 1.122310305775764 from the last closing price. This prediction may vary from other time period filters for HQL stock.

What can be the highest Possible price of HQL stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, HQL can achieve the highest price of $18.17 which is 2.916116541170332 higher than last closing price. This prediction may vary from other time period filters for HQL stock.

What can be the lowest Possible price of HQL stock in next 2 weeks?

As per the forecast and algorithmic analysis, HQL stock price can be as low as $17.58 which is -0.46001495672369946 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for HQL stock.

Will HQL stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that HQL stock will gain1.122310305775764 in the next 2 weeks. This prediction may vary from other time period filters for HQL stock.

What is HQL stock last closing price?

Last closing price of HQL stock was $17.66.

What is HQL stock price prediction?

HQL stock price prediction means predicting the future closing prices of HQL stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of HQL stock in a certain time period.

How we predict HQL stock future prices?

If you are searching for HQL stock forecast, analysis or price prediction, then you might be wondering what Tekla Life Sciences Investors (HQL) will do in the future. Our HQL price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This HQL price prediction will likely answer most of your questions.

How frequent we update HQL stock predictions?

We are updating the forecasts for the HQL stock on daily basis.

Is using ML forecasting for HQL stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for HQL stock same for all the time periods?

No, the prediction for HQL stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

Tekla Life Sciences Investors Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$17.66-1.62%Since 2 Weeks

Predicted Price$17.861.12%For 2 Weeks

Upper Predicted Price$18.172.92%For 2 Weeks

Lower Predicted Price$17.58-0.46%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of HQL will rise by +1.12% over the next 2 Weeks and hit $17.86 by Wednesday, June 3, 2026. In that time frame, HQL's share price is expected to range between $17.58 and $18.17.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jun 3, 2026	17.58	17.86	18.17
Jun 2, 2026	17.45	17.72	18.02
Jun 1, 2026	17.34	17.62	17.91
May 29, 2026	17.41	17.68	17.97
May 28, 2026	17.37	17.65	17.90
May 27, 2026	17.47	17.73	17.98
May 26, 2026	17.31	17.59	17.84
May 25, 2026	17.24	17.49	17.75
May 22, 2026	17.30	17.55	17.82
May 21, 2026	17.24	17.52	17.75

HQL shares fell -3.06% in Thursday, May 21, 2026's trading session, dropping from a previous close of $17.66 to move at $17.12. The stock demonstrated notable intraday movement (see HQL's key stats for a full breakdown), fluctuating between $17.03 and $17.18, a +0.88% trading range. While recent weeks have seen some volatility, HQL has managed to secure a -4.62% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 179.04K shares changing hands, 48.69K more than the previous session. This amounted to $3.07M in total market activity.

Will HQL Continue Its Upward Trend?

According to analyst ratings and projections for HQL, Tekla Life Sciences Investors shares are anticipated to increase by +5.80%, potentially reaching $18.17 per share by June 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for HQL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the HQL stock forecast, now is a good time to buy HQL stock because its current trading price is -4.13% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on HQL covering social and institutional perspectives.

HQL Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into HQL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 33.92% to 44.96%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 50.44%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 52.25%, maintains a neutral outlook for the long term. Insights into HQL's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Tekla Life Sciences Investors Short-Term Forecasts

HQL Forecast For Next 5 Days

Our algorithm anticipates Tekla Life Sciences Investors (HQL) stock could hit $17.03 by May 28, 2026. This represents a -0.52% fall from today's price, following a -0.60% change over the past five days.

HQL Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Tekla Life Sciences Investors (HQL) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $17.05, which would mean a -0.41% decrease from the current price of $17.12. Projections for this period range from a high of $18.44 to a low of $15.93.

HQL Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Tekla Life Sciences Investors's price over the next three months point to a rise. HQL stock is expected to peak at $18.69 on Aug 20, 2026 after potentially dipping to $16.90 on May 22, 2026. On average, HQL is likely to trade around $17.84 in the coming 90 days.

Tekla Life Sciences Investors Stock Forecast 2025

Based on our predictive models, Tekla Life Sciences Investors (HQL) is expected to trade between $16.90 and $20.08 throughout 2026. This would result in an average price of $18.05, potentially offering investors a +5.43% return from current levels.

Tekla Life Sciences Investors Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, Tekla Life Sciences Investors (HQL) is positioned to show a strong performance in May 2026. The price is predicted to move between $16.90 and $18.06, settling at an average of $17.50. This could translate to a +2.22% gain.

June 2026

Based on current market signals, Tekla Life Sciences Investors is projected to trend june 2026. We forecast a trading range from $17.09 to $18.48, with a likely average price of $17.79. Investors could expect a potential return of +3.91%.

July 2026

Our predictive algorithms indicate Tekla Life Sciences Investors stock may see a shift in July 2026. The expected range spans $17.12–$18.67, with an average target of $17.85. This represents a positive outlook and a possible gain of +4.26%.

August 2026

Analyzing established trends, Tekla Life Sciences Investors looks set to move in August 2026. Projections place the stock between $17.30 and $18.70, averaging around $18.09. This suggests a +5.67% gain from current levels.

September 2026

Market indicators suggest Tekla Life Sciences Investors could experience notable changes during September 2026. Prices could fluctuate within $17.45 to $18.78, with a midpoint forecast of $18.15. The stock might deliver a +6.02% gain.

October 2026

Forecasting for October 2026, models estimate that Tekla Life Sciences Investors may undergo key fluctuations. If trends hold, the stock might trade between $17.27 and $19.12, averaging $18.11. This signals a positive trajectory with potential returns around +5.78%.

November 2026

According to our latest forecast models, Tekla Life Sciences Investors (HQL) is positioned to show a strong performance in November 2026. The price is predicted to move between $17.59 and $20.08, settling at an average of $18.29. This could translate to a +6.83% gain.

December 2026

Based on current market signals, Tekla Life Sciences Investors is projected to trend december 2026. We forecast a trading range from $17.60 to $18.99, with a likely average price of $18.28. Investors could expect a potential return of +6.78%.

January 2027

Our predictive algorithms indicate Tekla Life Sciences Investors stock may see a shift in January 2027. The expected range spans $17.85–$19.08, with an average target of $18.51. This represents a positive outlook and a possible gain of +8.12%.

February 2027

Analyzing established trends, Tekla Life Sciences Investors looks set to move in February 2027. Projections place the stock between $17.83 and $19.20, averaging around $18.57. This suggests a +8.47% gain from current levels.

March 2027

Market indicators suggest Tekla Life Sciences Investors could experience notable changes during March 2027. Prices could fluctuate within $17.76 to $19.32, with a midpoint forecast of $18.51. The stock might deliver a +8.12% gain.

April 2027

Forecasting for April 2027, models estimate that Tekla Life Sciences Investors may undergo key fluctuations. If trends hold, the stock might trade between $17.96 and $19.35, averaging $18.64. This signals a positive trajectory with potential returns around +8.88%.

May 2027

According to our latest forecast models, Tekla Life Sciences Investors (HQL) is positioned to show a strong performance in May 2027. The price is predicted to move between $18.04 and $19.35, settling at an average of $18.62. This could translate to a +8.76% gain.

HQL's history of dividends and stock splits also plays a role in long-term investor confidence.